The usage of a simplified self-titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes--results of the randomized, controlled PREDICTIVE 303 study (Q46959407)

From Wikidata

Jump to navigation Jump to search

scientific article published in November 2007

Language	Label	Description	Also known as
English	The usage of a simplified self-titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes--results of the randomized, controlled PREDICTIVE 303 study	scientific article published in November 2007

Statements

scholarly article

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17924873

The usage of a simplified self-titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes--results of the randomized, controlled PREDICTIVE 303 study (English)

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17924873

type 2 diabetes

0 references

0 references

1 reference

based on heuristic

inferred from title

insulin detemir

1 reference

based on heuristic

inferred from title

author name string

Meneghini L

1

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17924873

Koenen C

2

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17924873

Weng W

3

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17924873

Selam JL

4

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17924873

publication date

1 November 2007

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17924873

Diabetes, Obesity and Metabolism

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17924873

9

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17924873

902-913

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17924873

6

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17924873

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00804.X

21 January 2018

Influence of intensive diabetes treatment on body weight and composition of adults with type 1 diabetes in the Diabetes Control and Complications Trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00804.X

21 January 2018

Albumin binding of insulins acylated with fatty acids: characterization of the ligand-protein interaction and correlation between binding affinity and timing of the insulin effect in vivo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00804.X

21 January 2018

Albumin-bound basal insulin analogues (insulin detemir and NN344): comparable time-action profiles but less variability than insulin glargine in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00804.X

21 January 2018

Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00804.X

21 January 2018

Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00804.X

21 January 2018

Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00804.X

21 January 2018

Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00804.X

21 January 2018

Comparison of three multiple injection regimens for Type 1 diabetes: morning plus dinner or bedtime administration of insulin detemir vs. morning plus bedtime NPH insulin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00804.X

21 January 2018

Insulin detemir and insulin aspart: a promising basal-bolus regimen for type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00804.X

21 January 2018

Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00804.X

21 January 2018

Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimen

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00804.X

21 January 2018

Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00804.X

21 January 2018

Insulin detemir used in basal-bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00804.X

21 January 2018

Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00804.X

21 January 2018

Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00804.X

21 January 2018

Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00804.X

21 January 2018

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00804.X

21 January 2018

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00804.X

21 January 2018

Standards of medical care in diabetes--2007.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00804.X

21 January 2018

Does insulin detemir have a role in reducing risk of insulin-associated weight gain?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00804.X

21 January 2018

Comparison of the effects on glucose and lipid metabolism of equipotent doses of insulin detemir and NPH insulin with a 16-h euglycaemic clamp

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00804.X

21 January 2018

Safety and efficacy of insulin detemir in clinical practice: 14-week follow-up data from type 1 and type 2 diabetes patients in the PREDICTIVE European cohort

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00804.X

21 January 2018

Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00804.X

21 January 2018

Identifiers

10.1111/J.1463-1326.2007.00804.X

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17924873

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17924873

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46959407&oldid=2139715463"